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Abstract  17 
Oxysterols are critical regulators of inflammation and cholesterol metabolism in cells. They are 18 
oxidation products of cholesterol and may be differentially metabolised in subcellular 19 
compartments and in biological fluids.  New analytical methods are needed to improve our 20 
understanding of oxysterol trafficking and the molecular interplay between the cellular 21 
compartments required to maintain cholesterol/oxysterol homeostasis. Here we describe a 22 
method for isolation of oxysterols using solid phase extraction and quantification by liquid 23 
chromatography-mass spectrometry, applied to tissue, cells and mitochondria. 24 
We analysed five monohydroxysterols; 24(S)-hydroxycholesterol, 25-hydroxycholesterol, 27-25 
hydroxycholesterol, 7α-hydroxycholesterol, 7 ketocholesterol and three dihydroxysterols 7α-26 
24(S)dihydroxycholesterol, 7α-25dihydroxycholesterol, 7α-27dihydroxycholesterol by LC-MS/MS 27 
following reverse phase chromatography. Our new method using Triton and DMSO extraction, 28 
shows improved extraction efficiency and recovery of oxysterols from cellular matrix. We 29 
validated our method by reproducibly measuring oxysterols in mouse brain tissue and showed 30 
that mice fed a high fat diet had significantly lower levels of 24S/25diOHC, 27diOHC and 31 
7ketoOHC. We measured oxysterols in mitochondria from peripheral blood mononuclear cells 32 
and highlight the importance of rapid cell isolation to minimise effects of handling and storage 33 
conditions on oxysterol composition in clinical samples. In addition, in vitro cell culture systems, 34 
THP-1 monocytes and neuronal-like SH-SH5Y cells showed mitochondrial-specific oxysterol 35 
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metabolism and profiles were lineage specific. In summary, we describe a robust and 36 
reproducible method validated for improved recovery, quantitative linearity and detection, 37 
reproducibility and selectivity for cellular oxysterol analysis. This method enables subcellular 38 
oxysterol metabolism to be monitored and is versatile in its application to various biological and 39 
clinical samples. 40 
Keywords  41 
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Introduction 45 
Oxysterols are biologically important molecules that regulate cell signalling, contribute to 46 
regulating cholesterol homeostasis and are essential for bile acid and steroid hormone 47 
biosynthesis [1]. Oxysterols are formed by oxidation and addition of hydroxyl groups onto 48 
cholesterol hydrocarbon rings and side chains [2,3]. Enzymatic catalysed additions of hydroxyl to 49 
the side chain by cytochrome P450 (CYP) enzymes generate mono- and di-hydroxysterols; 50 
24(S)-hydroxycholesterol (24OHC), 25-hydroxycholesterol (25OHC), 27-hydroxycholesterol 51 
(27OHC), 20-hydroxycholesterol, 22-hydroxycholesterol, 7α-24(S)-dihydroxycholesterol 52 
(24SdiOHC), 7α-25-dihydroxycholesterol (25diOHC) and 7α-27-dihydroxycholesterol (27diOHC) 53 
[4]. Hydroxylation of the hydrocarbon rings occurs by free radical attack forming hydroxylated 54 
sterols 7α-hydroxycholesterol (7αOHC) and 7β-hydroxycholesterol, oxysterols with a ketone 55 
group 7-ketocholesterol (7ketoOHC), epoxy cholesterols [5β, 6β- epoxy cholesterol (5β, 6β-56 
epox), 5α, 6α- epoxy cholesterol (5α, 6α-epox) and cholestan-3β, 5α, 6β‑triol [5,6].  57 
The cellular localisation of enzymes responsible for oxysterol generation is critical to local 58 
oxysterol homeostasis [2]. In addition, the redox states of subcellular compartments are different; 59 
the endoplasmic reticulum (ER) has a strong reducing environment to enable protein folding, 60 
whereas the mitochondria stores glutathione but is exposed to greater potential for oxidation from 61 
reactive oxygen species (ROS) leakage by the electron transport chain, increasing the potential 62 
for local cholesterol autoxidation [2]. Interaction between endosomes, ER, mitochondria, cell 63 
membrane, peroxisomes and lysosomes is necessary for cholesterol and oxysterol trafficking 64 
and sterol homeostasis intracellularly; for instance, cholesterol is transported to mitochondria 65 
from the ER either by direct membrane contact between ER and mitochondria, or mobilised in 66 
lipid droplets (cholesterol esters) [7,8]. In mitochondria, the steroidogenic acute regulatory protein 67 
(StAR) transports cholesterol from the outer to inner membrane and controls mitochondrial sterol 68 
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trafficking [7,9]. Less is known about oxysterol trafficking between the subcellular compartments 69 
[2]. 70 
Changes to oxysterol levels are implicated in the pathogenesis of several diseases and targeting 71 
cholesterol and oxysterol dyshomeostasis may provide a platform for development of novel 72 
therapeutics. Dysregulation of cholesterol metabolism has been associated with metabolic 73 
diseases such as cancer, heart and liver diseases and motor neurone diseases [2,10,11].  74 
Oxysterols are known to be cytotoxic at high concentration; accumulation of 7-ketoOHC in 75 
lysosomes triggered membrane destabilization and induced cell death in human monocytic U937 76 
cells [12]. At a subcellular level, accumulation of 7-ketoOHC and 7β-hydroxycholesterol by 77 
cholesterol autoxidation caused redox imbalance and peroxisomal dysfunction in nerve cells [13, 78 
14]. Mitochondrial dysfunction and aberrant oxysterol metabolism have been recognized in the 79 
pathogenesis of diseases such as atherosclerosis, carcinogenesis and multiple 80 
neurodegenerative diseases including Alzheimer’s disease [15–20]. In vitro studies have shown 81 
that the addition of 7β-hydroxysitosterol and 7β-OHC induced loss of mitochondrial membrane 82 
potential, membrane permeabilisation, oxidative stress and apoptosis in human colon cancer, 83 
Caco-2 cells [21]. Again, high concentrations of 24OHC caused necroptosis in human 84 
neuroblastoma SH-SY5Y cells whereas sublethal concentrations of 24OHC induced protection 85 
against cytotoxic stress in these cells [22,23]. Similarly, accumulation of 25OHC has been shown 86 
to inhibit inflammasome activation in macrophages [24]. In neurodegenerative conditions, such 87 
as Alzheimer’s disease, oxysterol levels are linked to neuroinflammation, mitochondrial oxidative 88 
damage and cell death [25–27]. Thus, altered oxysterol metabolism at both cellular and 89 
subcellular levels associates with altered cell function and the pathogenesis of several chronic 90 
diseases. To improve understanding of any contribution of oxysterols to disease and in particular, 91 
to explore the mitochondria-oxysterol association and role in disease, there is a need to 92 
reproducibly measure oxysterols in different subcellular compartments. 93 
Oxysterols are ~10-1000 fold lower in abundance as compared to cholesterol in cells and 94 
biological fluids [2,28].The structural and chemical properties of oxysterols are similar to each 95 
other and pose a challenge in detection and quantification using analytical techniques [2,29,30]. 96 
Analysis of oxysterols has been performed by both gas chromatography-mass spectrometry and 97 
high performance liquid chromatography-mass spectrometry (HPLC-MS) with the latter providing 98 
more sensitive targeted detection of sterols with the advanced technique of multiple reaction 99 
monitoring (MRM) or MS/MS that tracks precursor to product ion formation [31-33]. Oxysterol 100 
quantification using LC-MS/MS has emerged as a popular analytical method, developed and 101 
adopted by many research groups. A number of methods have been described to date for 102 
measuring oxysterols in human plasma, serum, and cerebrospinal fluid, and these methods 103 
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involve derivatisation of oxysterol moieties for subsequent quantifications [34-36]. Dias et al., 104 
2018 developed a multistep LC gradient for efficient direct MS detection and quantification of 105 
oxysterols from human plasma reducing the risk of artefactual oxidation during sample 106 
processing [29]. The application of LC-MS methods for cellular oxysterol analysis is an emerging 107 
field and has recently been applied in dietary intervention studies [29,37,38], for example Beck et 108 
al., 2018 isolated and quantified oxysterols from carp cell lines, showing an increase in cellular 109 
25diOHC after exogenous supplementation with 25OHC.  110 
Oxysterol content also differs according to the cell type, tissue and organism [2]. The different 111 
structural composition of discrete cells, tissue and biological fluids requires that the methods for 112 
isolation of lipids and oxysterols are tailored for the biological sample under study. To date, no 113 
comprehensive method for oxysterol quantification at cellular and subcellular levels has been 114 
reported. In this study, we describe the isolation of mitochondria from whole cells, followed by 115 
isolation of lipids and oxysterols from mitochondria. We adapted our LC-MS/MS method for 116 
characterisation of mono and dihydroxycholesterols from mitochondria.  117 
Here we have compared our newly developed method to two previously published methods for 118 
extraction of lipids in mitochondrial isolates from tissues by Bird et al., 2013 [38] and for 119 
measuring free oxysterols in plasma by Dias et al., 2018 [29]. Our newly developed method 120 
shows improved recovery, selectivity and highly sensitive detection and quantification of 121 
oxysterols from discrete cellular compartments. Oxysterol distribution in whole cell and 122 
mitochondrial isolates were profiled in THP-1 monocytes, SH-SY5Y neuroblastoma cell and 123 
peripheral blood mononuclear cells (PBMC) isolated from whole blood of healthy individuals. Our 124 
analysis showed differential oxysterol distribution across cell types indicating cell and tissue 125 
specific oxysterol metabolism. Furthermore, measurement of mitochondrial specific oxysterol 126 
profile indicated local metabolism of oxysterols that was distinct from the whole cell and 127 
endoplasmic reticulum. This method enables quantification of oxysterols in mitochondria to 128 
elucidate compartment specific metabolism in clinical samples. 129 
2. Materials and Methods 130 
2.1. Ethical statement for blood and mouse tissue samples 131 
Blood samples were collected from healthy volunteers with ethics committee approval and with 132 
informed consent. 133 
The mouse experimental procedures were conducted under the State Council of the People's 134 
Republic of China (Decree No. 2 of the State Science and Technology Commission) October 31, 135 
1988. Amendment Regulations and approval of the local ethics committee for use effective 136 
March 1, 2017. The experimental procedures in the University of Surrey received ethical 137 
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clearance under NASPA ethical review assessment under reference number NERA-2017-011-138 
Bio. Effective date 26/09/2019.  139 
2.2. PBMC isolation from blood 140 
2.2.1. Blood samples 141 
Blood samples were collected from healthy individuals and were kept one hour at room 142 
temperature or 24, 48 and 72 h at 4°C. Whole blood (10ml) was diluted 1:1 with RPMI + 143 
GlutaMAX, layered onto Histopaque-1077 (Sigma) and centrifuged at 1000g for layer separation. 144 
The PBMC layer was retained, washed and resuspended in 9ml STE buffer (250mM Sucrose, 145 
5mM Tris and 2mM EGTA, pH7.4)/ 0.5% BSA (purchased from Sigma Aldrich)).  146 
2.3. Cell culture 147 
The human monocytic THP-1 cell line (ATCC TIB-202) was grown in RPMI 1640 medium 148 
supplemented with 10% heat inactivated fetal bovine serum (FBS) at 37⁰C, 5% CO2 and 95% 149 
humidity. Reagents were purchased from Sigma Aldrich. SH-SY5Y cells were grown in 150 
Dulbecco’s modified Eagle’s medium/F-12 with GlutaMAX supplemented with 10% (v/v) foetal 151 
bovine serum, and penicillin (100U/ml) and streptomycin (100µg/ml). Cell cultures were grown to 152 
6 x 15cm plates at 80-90% confluency and harvested through trypsinisation. The cell pellet was 153 
washed in DMEM/F12 media before resuspending in STE/0.5 % BSA and proceeding with 154 
homogenisation and mitochondrial isolation as described above for blood samples.  155 
2.4. Subcellular fractionation and mitochondrial isolation 156 
SH-SY5Y cells (107 cells) were trypsinised and collected by centrifugation at 1000g for 5 mins.  157 
PBMCs, THP-1 monocytes and SH-SY5Y cells were washed with phosphate buffer saline prior to 158 
subcellular fractionation and mitochondrial isolation using a method developed by Kappler et al., 159 
2016 [39]. Cells were re-suspended in 9ml STE + 0.5% BSA (250mM Sucrose, 5mM Tris and 160 
2mM EGTA, pH7.4)/ 0.5% BSA) buffer and placed on ice prior to homogenisation using a loose 161 
fitted 40ml Wheaton Dounce tissue grinder containing a further 9ml of buffer. 1ml of the cell 162 
homogenate was collected separately for whole cell (WC) analysis with the remaining 163 
homogenate centrifuged at 1000g for 10 minutes at 4°C, with pellets re-suspended and this step 164 
repeated. A crude mitochondrial pellet was obtained by centrifugation of the supernatant at 165 
10,400g for 10 minutes at 4°C. To gain a purer mito chondrial fraction this pellet was resuspended 166 
in 200µl STE, layered onto 25% Percoll gradient (25% Percoll (GE Healthcare), 25% 2xSTE and 167 
50% STE + 0.5% BSA) and ultracentrifuged at 80,000g for 20 minutes at 4°C. The resultant 168 
ER/mitochondria and enriched mitochondrial layers were extracted, washed with STE followed by 169 
PBS, resuspended in molecular grade water and stored at -80oC. For PBMCs and SH-SY5Y 170 
cells, three fractions mitochondrial (M), ER/M and WC were analysed. The following THP-1 171 
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monocyte subtractions, WC, M, ER/M and WCR (remaining WC fraction pellet without M and 172 
ER/M, obtained after first centrifugation step of the homogenate), were used for method 173 
development and validations.  174 
2.4.1 Western blot analysis of mitochondrial isolates 175 
Protein quantification was performed using a Pierce bicinchoninic acid protein assay kit 176 
(ThermoFisher), with electrophoresis using SDS-PAGE and immunodetection using calnexin 177 
(Abcam, ab22595) and ATP5A (Abcam, ab14748) followed by fluorescent DyLight secondary 178 
antibodies (Invitrogen, SA5-10036 and 35519) and visualisation using a CLx imaging system 179 
scanner (LI-COR Bioscience), using Geneflow BLUeye protein ladder (245kDa) ladder. 180 
2.5. High fat diet-fed mouse experiments and brain tissue sections 181 
Four weeks old C57BL/6 male mice were maintained in Nanjing- China SPF animal facility on a 182 
07.00-19.00 day/light cycle at 20-22°C with food an d water ad libitum. They were housed four in 183 
a cage and fed either control (normal) diet or high fat diet (HFD) ad libitum for four weeks. The 184 
body weight of the mice was taken every week. The animals in HFD treated group were fed a 185 
60% fat, 20% carbohydrate and 20% protein per kcal% while the animals in the control group 186 
received a 10% fat, 70% carbohydrate and 20% protein per kcal%. At the end of their respective 187 
periods of feeding mice were culled through cervical dislocation for tissue collection. Isolated 188 
serum was aliquoted, snap frozen and stored at -80°C freezer. Brains were removed, and with 189 
systematic sampling part of the tissues were snap frozen and stored at -80 °C. Brain tissues 190 
(n=5) from control and high fat diet (HFD) mice were sectioned into ~50mg hemispheres, 191 
weighed and used for lipid extraction. 192 
2.6. Isolation of lipids from tissues, cell lines and blood PBMCs 193 
Sample lysis: Mouse tissue (10-50mg) was weighed and re-suspended in 70µl of 0.1% Triton X-194 
100, 40µl dimethylsulfoxide (DMSO) and 5µl of butylatedhydroxytoluene (BHT) (90 mg.ml-1) as 195 
an antioxidant. Tissue sections were disrupted using a handheld rotor-stator homogenizer 196 
TissueRuptor II for disruption of tissues sections. The homogeniser probe was cleaned with 197 
ethanol/water- 30 seconds cycle and tissue disruption was carried out for 30 seconds (until the 198 
material homogenised), followed by cleaning of the probe. Whole cells (THP-1 monocytes, 199 
neuroblastoma SHY-5Y cell lines and blood PBMC), mitochondria and endoplasmic 200 
reticulum/mitochondria fractions were re-suspended in lysis buffer 70µl of 0.1% Triton X-100, 201 
40µl DMSO and 5µl of BHT (90 mg.ml-1).  202 
Homogenised tissue and cellular fractions were sonicated in the lysis buffer for 20 minutes. 203 
Standards and quality controls were prepared by adding a range of concentrations of each of the 204 
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9 authentic oxysterols (0, 0.005, 0.010, 0.025, 0.050, 0.075, 0.1, 0.25, 0.5, 0.75 and 1ng.µl-1) 205 
within a mix into 30µl of whole cell lysate used as the matrix, followed by addition of lysis buffer 206 
and sonication for 20 minutes. 3µl of 22SOHC-D7 (50ng.µl-1) external standard was added to the 207 
samples and standards and vortexed. Lipid extraction was carried out in fume hood following the 208 
method of Bird et al., 2013, with modifications adapted for this work. 190µl of LC-MS grade 209 
methanol (MEOH) and 380µl of dichloromethane (DCM) were added to the 110µl- 1 sample 210 
lysates and standards and vortexed for 20 seconds. 120µl of LC-MS grade water was added to 211 
the samples and standards, vortexed for 10 seconds and the tubes were allowed to stand at 212 
room temperature for 10 minutes. Samples and standards were centrifuged at 7168g, 8°C for 10 213 
minutes. The upper and interphase phase of extract was collected separately, dried and used for 214 
protein analysis. The lower DCM layer ~350 µl with the lipid extract was collected separately and 215 
dried under N2 gas using Turbovap LV purchased from Biotage. A fraction of the lipid extract 216 
(15µl) was collected separately and dried for cholesterol quantification. 217 
 2.7. Oxysterol extraction  218 
The dried DCM lower phase was reconstituted in 500µl of MEOH and 1.5ml of LC-MS grade 219 
water containing 0.1% formic acid and mixed well. A vacuum manifold connected to a 220 
multichannel filtration apparatus was used for the extraction of oxysterols. Oasis HLB solid phase 221 
extraction (SPE) cartridges (Waters) were used for selective separation of oxysterols from the 222 
lipid extracts. Cartridges were fitted into the vacuum manifold and primed with 800µl MEOH and 223 
600µl H2O + 0.1% formic acid. Samples were added slowly to the cartridges and the flow through 224 
was discarded. Samples were washed with 600µl H2O + 0.1% formic acid and 600µl hexane to 225 
remove polar non-binding analytes and excess cholesterol. Butyl acetate (1ml) was added to the 226 
cartridges and eluates were collected in a fresh tube with a controlled flow of 1 drop per second. 227 
Butyl acetate eluates were dried under N2 gas and reconstituted in 40µl of 40% MEOH containing 228 
0.1% formic acid.  229 
2.8. LC-MS/MS analysis 230 
Standards (10µl) and samples (20µl) were injected into a NUCLEOSIL C18 column (100-5 125/2) 231 
fitted with a guard column for the liquid chromatography (LC) analysis. Our previously developed 232 
solvent composition in Dias et al., 2018 was used for separation of oxysterols. Solvent A is 70% 233 
MEOH, 10% water, 0.1% formic acid   and solvent B is 90% isopropanol, 10% MEOH and 0.1% 234 
formic acid. A multistep solvent gradient was applied using ACQUITY Ultra performance liquid 235 
chromatography (UPLC) quaternary system purchased from Waters. The LC method used here 236 
was developed previously by Dias et al., 2018, and was set to 0 minutes 16% B- 7 minutes 16% 237 
B; 7 minutes 16% B-11 minutes 24% B; 11minutes 24%B-25 minutes 100%B; 25 minutes 238 
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100%B-30 minutes 100% B; 30 minutes 100% B- 32 minutes 16% B and was held at 16% B up 239 
to 48 minutes. Mass spectrometry analysis was performed using a Xevo TQ-S Triple Quadrupole 240 
Mass Spectrometer (Waters) and operated with the positive electrospray ionisation (ESI) mode. 241 
Nitrogen gas is used for desolvation at 500°C and a  flow rate of 900 litre/hour-1 and collision gas 242 
argon at a flow rate of 0.15 ml/minute-1 for collision. MRM transitions were set up using authentic 243 
oxysterol standards (Avanti Polar) lipids. Standards include- 24(S) hydroxycholesterol (700061P), 244 
25-hydroxycholesterol (700019P), 27-hydroxycholesterol (700021P), 7α-hydroxycholesterol 245 
(700034P), 7 ketocholesterol (700015P), 7α,27-dihydroxycholesterol (700136P), 7α,24 (R/S)-246 
dihydroxycholesterol (700119P), 7α,25-dihydroxycholesterol (700078P). The mass spectrometry 247 
method was set up with the MRM transitions for 9 analytes using the Intellistart feature in Xevo 248 
and are detailed in Table 1. The two best MRM transitions were identified for each analyte- the 249 
most abundant MRM as the quantifier and the second most abundant was used as the qualifier. 250 
Authentic oxysterols were dissolved in 50% methanol, 0.1% formic acid and working stocks were 251 
prepared in a range of 10ng.µl-1 to 50ng.µl-1. Analytes were infused directly into the MS system 252 
and transitions were determined manually by inspection of the chemistry of the analyte and 253 
optimisation of the ionisation parameters using the inbuilt Intellistart feature of the Xevo TQs 254 
system. Infusions were performed at 10-20µl min-1 and the cone voltage and collision energy 255 
were optimised in order to obtain the 5 best MRM transitions. 7α,24Sdihydroxychoelsterol 256 
(24SdiOHC) and 7α,25Sdihydroxychoelsterol (25diOHC) had identical MS/MS transitions and co-257 
eluted with identical retention times. So, these two analytes were analysed together as 258 
24S25diOHC for detection and quantification. For every batch of standards and samples, an 259 
unprocessed standard mixture and pooled samples were used as the quality control for the 260 
analyses. 261 
2.9. Cholesterol and protein quantification 262 
Cholesterol content in the lipid extract was quantified using the Invitrogen™ Molecular Probes™ 263 
Amplex™ Red Cholesterol Assay Kit (10236962) with 96 well plate assay set up that detects free 264 
and esterified cholesterol released from hydrolysis of cholesteryl esters. Protein was quantified 265 
using Pierce Bichinchonic acid assay kit (ThermoFisher) following the manufacturer’s protocol. 266 
Fluorescence (excitation-525 nm, emission- 585 nm) for Amplex™ Red cholesterol assay kit and 267 
absorbance (562 nm) for BCA assay kit were measured using SpectraMax i3x microplate reader 268 
and SoftMax Pro Software (Molecular Devices). The lower limit of quantitation (LLOQ) for 269 
cholesterol using the cholesterol assay kit and for protein weree verified to be 0.08ng.µl-1 and 270 
5ng.µl-1 respectively. 271 
2.10. Oxysterol quantification and data analysis 272 
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Mass spectrometry data was processed using MassLynx and TargetLynx software (Waters). 273 
Oxysterols were identified by comparing its retention time, exact mass, and MS/MS spectra to 274 
that of its authentic standard. To check the extraction efficiency and recovery of oxysterols from 275 
the cellular matrix, authentic standards were used. Authentic standards were mixed with cellular 276 
lysate prior to oxysterol extraction and LC-MS/MS analysis. A blank sample consisting of cell 277 
lysate and no authentic standard added was analysed in parallel to correct for interference from 278 
endogenous analytes. Peak Detection and integration was performed with ApexTrack integration 279 
feature built in MassLynx. ApexTrack integration automatically determines appropriate integration 280 
parameters for peak width and threshold. Peak areas were extracted for the quantifier MRM 281 
transition for each analyte. Standard curves were generated using the authentic oxysterols with 282 
concentrations 0, 0.005, 0.010, 0.025, 0.050, 0.075, 0.1, 0.25, 0.5, 0.75 and 1 ng.µl-1. Linear 283 
regression analysis was done to derive the equation for the line of best-fit and the concentration 284 
of oxysterols in samples was calculated from this equation. The limit of quantification (LOQ) was 285 
determined as per the US Food and Drug Administration (FDA) and the European Medicines 286 
Agency (EMA) guidelines of LLOQ defined as the lowest point on a calibration curve accepted 287 
based on an analytical precision cut-off of a 20% relative standard deviation. The lowest 288 
calibration curve point with co-efficient of variation < 20% was evaluated from six independent 289 
measurements (two replicates for each) done on different days was set as the LLOQ. 290 
Measurements below lower limit of quantification (LLOQ) were assigned LLOQ/2 values, 291 
following the models developed by Keizer et al., 2015 and Beal, 2001 to incorporate 292 
concentration data below the limit of quantification [40,41]. Graphs and statistical analysis 293 
including two-tailed student’s t-tests, ANOVA analysis and regression analysis were performed 294 
using Graphpad prism 8.0 and in Microsoft excel. Principal component analysis (PCA) was 295 
performed using IBM SPSS statistical analysis software.  296 
3. Results 297 
3.1. Extraction and characterisation of oxysterols from whole cell and mitochondria 298 
Cellular/subcellular fractions were generated from THP-1 monocytes, PBMC and SH-SH5Y 299 
neuroblastoma cells for investigation (Fig. 1A). Fraction enrichment was confirmed by western 300 
blotting using calnexin (ER) and ATP5A (mitochondrial) markers (Fig. S1).  Next, we isolated 301 
lipids and oxysterol pools from unfractionated whole cells and subcellular fractions (Fig. 1B, C) 302 
with authentic standards incorporated into whole cell (WC) lysate to mimic the effect of a cellular 303 
matrix, which may impair extraction efficiency. Eight authentic oxysterol standards were used 304 
(Table 1) and 22S-hydroxycholesterol-d7 (22SOHCD7) as the external standard for setting up the 305 
LC-MS/MS quantitation methodology (Fig. 1D).  306 
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The first extraction method M1, which had been established for human plasma [29], involved 307 
protein precipitation with methanol followed by oxysterol isolation using solid phase extraction 308 
(SPE) with polymeric reversed-phase sorbent. We developed a MS/MS method using a Waters 309 
Triple quad mass spectrometer to detect both mono and dihydroxycholesterols using the MRMs 310 
in Table 1. MRMs were set up by direct infusion of authentic standard into the mass spectrometer 311 
followed by optimization of cone voltage and collision energy to obtain two best transitions for 312 
each of the nine oxysterols.  313 
We employed our previously developed multistep gradient LC method using a C18 reverse phase 314 
(RP) column [29] for chromatographic separation of oxysterols (Fig. 1D). The three 315 
dihydroxysterols analysed by our LC-MS/MS produced two chromatographic peaks each due to 316 
their isomeric features (supplementary Fig. S2A,B). The two-peak feature was also observed with 317 
the 7α-dihydroxycholesterols reported by others using LC analysis [42,43]. The first 318 
chromatographic peak was the dominant one for the dihydroxycholesterols and as used in peak 319 
area analysis (Fig. S2A). The second peaks (peak 2) for 24S25diOHC and 27diOHC were 3/7th 320 
and 5/9th of the first peak respectively. We chose the first dominant peak for quantification 321 
because of the significantly larger peak area as compared to the second peak. This choice 322 
avoids the risk of losing quantification because of the non-detectability of the second peaks in 323 
samples with relatively low concentration of the dihydroxycholesterols. 324 
3.2. Extraction efficiency and recovery of oxysterols from cellular matrix 325 
Method M1 (our previously reported method for plasma) led to poor chromatographic detection of 326 
oxysterol authentic standards within the cellular matrix (Fig. 2A). The maximum recoveries for 327 
dihydroxysterols and monohydroxysterols from the cellular matrix using M1 were 27% and 9% 328 
respectively relative to the neat authentic standards analysed without cellular matrix and SPE 329 
extraction (Fig. 2B). We next explored method M2 for lipid extraction from rat liver tissues 330 
published in Bird et al., 2013 [38]. This method involved isolation of lipid pools following cell lysis 331 
in dimethylsulfoxide (DMSO), followed extraction of lipids by methanol (MeOH):dichloromethane 332 
(DCM) (1:2) solvent extraction. We extracted oxysterols from the total lipids using a solid phase 333 
extraction (SPE) separation technique as described in Dias et al., 2018. M2 also gave poor 334 
recovery of oxysterol standards as seen from chromatograms (Fig. 2C). M2 gave a maximum of 335 
48% for dihydroxysterols and 21% for monohydroxysterols (Fig. 2C). We speculated the poor 336 
recovery of oxysterols was due to the incomplete cell lysis and poor lipid extraction. Method M3 337 
yielded well resolved oxysterol peaks and improved chromatographic separation (Fig. 2A). We 338 
used 0.1% Triton X-100 and DMSO as detergents and BHT as an antioxidant during cell lysis. 339 
LC-MS/MS analysis showed enhanced recovery of both mono and dihydroxysterols standards in 340 
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WC matrix using the Triton cell lysis method (M3) (Fig. 2A, 2D, Fig. S2B). The recoveries of both 341 
mono and dihydroxycholesterols ranged from 74-100%.   342 
3.3. Method validation for subcellular oxysterol quantitation 343 
We used method M3 to generate standard curves with authentic oxysterols mixed in WC lysates 344 
in concentrations ranging from 5 pg.µl-1 to 1 ng.µl-1. Regression analysis produced an R2 ≥ 0.9 for 345 
all oxysterols confirming linearity between concentration of an analyte and its peak area (Fig. 346 
3A). The co-efficient of variation (CV) between the standard concentrations measured intra and 347 
inter days was calculated. The lower limit quantification (LLOQ) was set up with the lowest 348 
standard measurements that had a CV of <20% across intra- and inter-day measurements (Fig. 349 
3B). Precision of the standard curves were monitored with quality control (QC) samples 350 
consisting of eight oxysterols that showed a CV of ≤ 20%. THP-1 monocytes were used to set up 351 
the quantitation and for reproducibility analysis. Fig. 3C compares the chromatographic resolution 352 
of oxysterols from THP-1 monocytes using the three methods. Method M3 showed the highest 353 
extraction efficiency of oxysterols. We then checked the linearity of the LC-MS/MS method by 354 
quantifying oxysterols from THP-1 monocytes with varying cell numbers. We used 105, 106 and 355 
107 THP-1 cells as the starting material for extraction and quantification of oxysterols, cholesterol 356 
and protein (Fig. 3D, E, Supplementary Fig. S3). There were linear relationships between the 357 
number of monocytes used as the starting material, and monohydroxycholesterol, cholesterol 358 
and protein concentrations, implying 105 monocytes was the lower acceptable limit of starting 359 
material for detection of monohydroxycholesterols (Fig. 3E). However, 105 monocytes were 360 
insufficient for detection of dihydroxycholesterols (Fig. 3E). The limit of starting material for 361 
quantification of the three dihydroxycholesterols analysed here was 106 monocytes.  362 
We tested the reproducibility of oxysterol extraction and quantification in subcellular fractions - 363 
mitochondria (M), endoplasmic reticulum/mitochondria (ER/M) and remaining cell lysate (WCR) 364 
(Fig. 3F). Cellular fractions from 107 THP-1 monocytes were isolated on the same day and stored 365 
for two different lengths of time at -80⁰C, from one to seven days prior to oxysterol extraction 366 
and LC-MS/MS analysis. The amounts of oxysterol were normalised to the cholesterol quantified 367 
for each subfraction (Fig. 1). Cholesterol quantitation was performed using fluorometric 368 
cholesterol red assay and the LLOQ was verified to be 0.08 ng.µl-1. There were no statistically 369 
significant differences between the measurements of oxysterols and cholesterol after seven days 370 
of storage at -80⁰C (Fig. 3F, supplementary Fig. S4). The amounts of 25OHC and 7ketoOHC, 371 
the sterols that can also be generated by cholesterol autoxidation, did not vary significantly 372 
between Day 1 and Day 7 indicating negligible autoxidation under the storage conditions for 373 
fractionated cells in the presence of BHT and at -80°C. The data from Day 1 and Day 7 also 374 
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confirms the inter day precision of oxysterol extraction and LC-MS/MS analysis of samples 375 
fractionated and stored for up to one week. 376 
3.4. Application of the method to characterise tissue oxysterols 377 
We applied our optimised method M3 for oxysterol extraction and quantitation in tissues including 378 
mouse brain and whole blood (Fig. 4). We quantified oxysterols normalised to cholesterol in 379 
brains from two groups of mice, one fed on normal chow and one on high fat diet to validate the 380 
method (Fig. 4A). We show 24SOHC as the most abundant oxysterol in the brain tissues of both 381 
groups of mice, consistent with previous observations [43,44] (supplementary Fig. S5A). Our 382 
data shows 27OHC, 25OHC and 27diOHC as the next most abundant oxysterols, with levels at 383 
least 10-fold lower concentrations than 24SOHC (Supplementary Fig. S5A). The 384 
monohydroxysterol, 24SOHC, was also the most abundant sterol in high fat diet mice although 385 
the corrected levels of 24SOHC were reduced four fold from 6108.6 ± 2535 ng.µg-1 cholesterol in 386 
normal diet fed mice to 1512 ± 251 ng.µg-1 cholesterol in high fat diet mice (Fig. 4A). The brain 387 
levels of all oxysterols were lower in high fat diet fed mice with significant decreases in levels of 388 
24S25diOHC, 27diOHC and 7ketoOHC (Fig. 4A). This was not explained simply by the 389 
correction used for the elevated cholesterol levels in high fed diet mouse brain (twofold higher 390 
than that of the normal diet fed mice) (Fig. 4B). The analysis here established the versatility and 391 
applicability of the method to extract and quantify oxysterol from tissue sections and the 392 
biologically relevant and reproducible oxysterol distributions obtained from mouse brain.  393 
We applied our method to measure oxysterol profiles in whole blood PBMCs and their 394 
mitochondrial subfractions to validate the applicability of this method to clinical samples. Blood 395 
samples were collected from healthy individuals and were stored at four different conditions- 1h 396 
at room temperature, 24h at 4⁰C, 48h at 4⁰C and 72h at 4⁰C prior to PBMC and subsequent 397 
mitochondrial isolation. This analysis was used to determine optimal storage conditions for blood 398 
samples and to determine whether the various storage and handling conditions introduced 399 
variations in the subsequent subcellular oxysterol measurements. Oxysterols were extracted 400 
from whole PBMCs and mitochondria harvested from blood stored under the four aforementioned 401 
conditions and compared to analyse the effect of incubation times on oxysterols. Fig. 4C shows 402 
that the protein and cholesterol content in mitochondria and whole PBMC were not affected by 403 
storage, however, we observed a trend for increase in the 7ketoOHC profiles in the mitochondrial 404 
fraction with the increase in blood storage period (up to 12-fold; Fig 4D), suggesting that 405 
cholesterol autoxidation occurs in mitochondria fractionated from blood leukocytes with increased 406 
storage times. This trend of 7ketoOHC accumulation was not observed in whole PBMCs isolated 407 
from stored blood (supplementary Fig. S5B). Also, we did not observe such change in the protein 408 
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and cholesterol measurements, indicative of the small contribution of oxysterols to total 409 
cholesterol.  410 
The analysis here shows variations in subcellular oxysterol levels as a consequence of the 411 
experimental conditions used prior to oxysterol extraction, and that these variations were 412 
captured by the quantitation method developed in this study. The analysis highlights the 413 
importance of a standardised storage condition for analysis of clinical samples to minimise 414 
autoxidation. The analysis also showed differential oxysterol metabolism in brain and blood 415 
tissues. Unlike brain tissues, for which 24SOHC was the abundant sterol, in PBMC mitochondrial 416 
fractions and PBMCs, 27OHC and 7ketoOHC were the most abundant oxysterols indicating 417 
differences in oxysterol metabolism between tissues (supplementary Fig. S5C).  418 
3.5. Application of the method to profile mitochondrial oxysterols of cell lines 419 
The optimised method M3 was applied to measure oxysterol profiles in mitochondria, 420 
ER/mitochondrial and whole cell fractions of SH-SY5Y cells. We compared the mitochondrial and 421 
whole cell oxysterol profiles of SH-SY5Y to that of THP-1 monocytic cell lines and PBMCs in 422 
order to capture cell lineage specific differences. Fig. 5A and 5B shows principal component 423 
analysis (PCA) plots of SH-SY5Y vs. PBMC and SH-SY5Y vs. THP-1 oxysterols respectively. 424 
The oxysterol component profiles of SH-SY5Y were grouped distinctly to that of PBMC and THP-425 
1s respectively. The differences were pronounced in the mitochondrial and whole cell profiles of 426 
SH-SY5Y vs. THP-1 (Fig. 5B). In particular, the levels of 24S25diOHC, 27diOHC and 7ketoOHC 427 
were higher in THP-1 mitochondrial fractions than the SH-SY5Y mitochondrial fractions (Fig. 5C). 428 
In whole THP-1 monocytes, 27diOHC and 24SOHC were higher than that measured in SH-SY5Y 429 
cells (Fig. 5D). These analysis shows cell specific oxysterol metabolism with distinct 430 
mitochondrial profiles in the two cell types. We compared THP-1 profiles to that of PBMCs by 431 
PCA and show distinct grouping of the mitochondrial and whole cell profiles from THP-1 432 
monocytes (Fig. S6A).  433 
We next explored compartment specific oxysterol metabolism from whole cell (WC), mitochondria 434 
(M) and endoplasmic reticulum/mitochondria (ER/M) fractions of SH-SY5Y cells. The levels of 435 
total cholesterol were lower in M and ER/M fractions and oxysterol distributions were distinct in 436 
the subcellular compartments (Fig. S6B, 5E). For instance, 27OHC concentrations were 437 
significantly higher than the other enzymatically derived mono- and di-hydroxycholesterols in 438 
mitochondria, while 7ketocholesterol was the dominant oxysterol in ER/M and WC fractions. 439 
24SOHC was the least abundant oxysterol in mitochondria, while 24S25diOHC were the least 440 
abundant in ER/M and WC. The overall mitochondrial oxysterol concentrations were lower than 441 
in ER/M and WC fractions. 442 
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Compartment-specific oxysterol profiles were also determined in THP-1 monocytes and 443 
7ketoOHC was the predominant oxysterol in M and WC fractions (Fig. S6C). Unlike in SH-SY5Y 444 
cells, where the overall mitochondrial oxysterol concentrations were lower than in ER/M and WC 445 
fractions, the oxysterol levels in the three compartments of THP-1 monocytes were comparable 446 
albeit the levels of cholesterol in M and ER/M fractions were over tenfold lower than that in the 447 
WC (Fig. S6D). These analyses confirm that oxysterol profiles are distinct between mitochondria, 448 
endoplasmic reticulum/ mitochondria and whole cells, confirming compartment specific oxysterol 449 
metabolism in cells. 450 
 451 
4. Discussion 452 
Recent advances in high throughput analytical techniques have enabled measurement of 453 
oxysterols in various biological systems [16,32,45]. Our newly developed method allowed 454 
simultaneous detection of mono and dihydroxycholesterols across mouse brain tissues, cell lines 455 
and blood samples, providing a versatile method that can be applied to various biological 456 
samples. 457 
Extraction efficiency and recovery of oxysterols from cells and tissues without artefactual 458 
oxidation is critical for quantitation, because endogenous sterols are present in trace amounts in 459 
cells and tissues (Dias et al., 2018). Here we used authenticated standards to confirm the 460 
extraction efficiency/recovery, which was > 74% for the nine sterols including the external 461 
standard. The use of surrogate heavy stable isotope-labelled standards offers an additional 462 
advantage to check and correct for the chromatographic shifts in the peak width and retention 463 
times for endogenous analytes. They may be evaluated to replace the external deuterated 464 
standard and used for quantitation if they have identical recovery and matrix effects as the 465 
analyte of interest. Our previously developed method (Dias et al., 2018) was successfully 466 
employed to quantify monohydroxycholesterols in plasma. Although this method allowed >80% 467 
recovery of sterols from a plasma matrix, it failed to provide similar recovery of sterols from a cell 468 
matrix, confirming the essential requirement to tailor methods for optimal oxysterol extraction 469 
efficiency in cells and tissues. Eukaryotic cells are highly compartmentalised systems with 470 
cholesterol and oxysterol metabolism localised in specific subcellular compartments [2,46]. 471 
Therefore, complete cell lysis and release of oxysterol pools from the cellular niche has required 472 
a new rigorous method, as developed in this study, using Triton X-100 for efficient extraction.  473 
Autoxidation of cholesterol during sample processing is a critical factor to account for during 474 
sterol analysis [29,47]. Use of antioxidants and also an initial separation step to remove 475 
cholesterol is adopted to minimize risk of autoxidation artefacts. Use of SPE columns for 476 
cholesterol removal is a widely accepted oxysterol selective technique that was also included in 477 
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our method [29,30]. A previous study reported the use of SPE silica columns to cause a 1 to 3% 478 
cholesterol autooxidation to 5/6(a/b)-epoxycholesterol [32]; however, the effect of such oxidation 479 
and biological interference was shown to be minimal in our previous study [29]. Also, our current 480 
method did not result in any change to oxysterol levels particularly in 7ketoOHC that could be 481 
generated by autoxidation from cholesterol during sample storage, handling and extraction 482 
process if the cells were stored intact. The extraction and quantitation performed on two different 483 
days for THP-1 cells did not lead to any significant variation in subcellular oxysterol distribution.  484 
However, blood stored under four different conditions (time and temperature) prior to PBMC 485 
harvest and cellular fractionation, introduced biological variation, including increased cholesterol 486 
autoxidation to 7ketoOHC particularly in mitochondria. The effects of processing and handling on 487 
clinical specimens have already been recognized and evaluated for serum and plasma samples 488 
where standardized procedures are advised to avoid confounding factors and bias for validation 489 
studies and biomarker discoveries [48]. Following from our analysis, we stress the practice of 490 
uniform clinical sample handling and minimal blood storage time to avoid autoxidation artefacts 491 
that may arise e.g. from mitochondrial oxidative stress during storage that was measured here as 492 
mitochondrial 7ketoOHC and which was not present in whole cell PBMCs.  493 
 494 
The choice of solvent compositions for HPLC sterol analysis affects the signal intensity. 495 
Acetonitrile as a mobile phase has negative effects on the electrospray ionisation process and 496 
reduction in signal intensity of oxysterols due to adduct formations [32]. Solvent compositions of 497 
methanol/water are preferably and widely used for LC oxysterol analyses [3,32,49]. In our 498 
method we used a multistep gradient composed of methanol/water/isopropanol that allowed 499 
baseline separation of the monohydroxycholesterols and in particular, separation of the two 500 
critical oxysterols- 24SOHC and 25OHC [29]. A limitation of existing LC methods is the co-elution 501 
of the two dihydroxycholesterols- 24SdiOHC and 25diOHC. These two are difficult to resolve by 502 
LC and also by MS/MS because of their identical MRM transitions. The two 503 
dihydroxycholesterols could not be separately resolved on the C-18 reverse phase, because of 504 
the weaker interaction between these analytes and the column bed. In the future, the baseline 505 
resolution of these dihydroxycholesterols may be improved by new alternate column chemistry.  506 
 507 
We evaluated the biological validity of our method for oxysterol analysis by measuring oxysterol 508 
profiles from mouse brain sections. In alignment with other studies by Griffiths and Wang, 2006, 509 
our method also identified 24SOHC as the most abundant oxysterol in mouse brain. Our results 510 
also showed significant decrease in 24S25diOHC, 27diOHC and 7ketoOHC levels after an 511 
increase in dietary fat intake. Lower concentrations of dihydroxysterols may be indicative of 512 
cholesterol accumulation in the ER, leading to ER stress and impaired activity of specific ER 513 
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cholesterol metabolising enzymes such as Cyp7b1 [50]. Previous studies have described the 514 
association between increased dietary cholesterol and dementia [51], and others have shown a 515 
decrease in 24SOHC and increase an in 27OHC and 7ketoOHC in post-mortem brains of 516 
patients with advanced dementia [52]. A different study evaluated the effects of high fat diet on 517 
hypothalamic oxysterols in C57BL/6 mice, showing high plasma cholesterol, no significant 518 
modifications 24SOHC and 27OHC and a decrease in the levels of 7ketoOHC consistent with our 519 
oxysterol measurements from brain tissues of high fat diet fed mice [53]. Guillemot-Legris et al., 520 
2015 also showed significant modifications in hepatic, plasma and adipose tissue oxysterols, 521 
4βhydroxycholesterol, 25OHC and 27OHC in a time course dependent manner. Sozen et al., 522 
2018 also evaluated the effects of high cholesterol diet on fatty acid, oxysterol and scavenger 523 
receptor levels in heart tissues of rabbits, and showed both cholesterol and oxysterols including 524 
4βhydroxycholesterol, 25OHC, 27OHC and 7ketoOHC levels were elevated in heart tissues of 525 
high cholesterol fed animals [54]. Taken together the findings from this study and the previous 526 
research suggests that the high fat dietary effects on oxysterol accumulation are tissue 527 
dependent.  528 
  529 
Biosynthesis and metabolism of oxysterols is distinctive within subcellular compartments with 530 
Cyp27A1 (mitochondrial specific sterol 27 hydroxylase) functions in the acidic pathway of bile 531 
acid synthesis and catalyses 27 hydroxylation of cholesterol to produce 27OHC (Fig. 6) [55, 56] 532 
and is expressed exclusively in mitochondria. However, whereas Cyp7b1, Cyp46A1 and 533 
Cyp39A1 are more prevalent in the ER [2,56,57] (Fig. 6). We measured compartment specific 534 
oxysterol profiles in SH-SY5Y and THP-1 cell lines, of neural and myeloid origin respectively 535 
[58,59], and showed markedly different oxysterol distribution between two cell models, 536 
particularly in the mitochondrial subfractions of the cells. A previous study adopted a 537 
radioisotopically labelled approach to trace oxysterol formation in THP1 cells [60].  After addition 538 
of labelled cholesterol, between 10-20% was converted to oxysterols within 24 hours. Here, we 539 
also measured a similar proportion of oxysterol to cholesterol in THP-1 monocytes but not in SH-540 
SY5Y cells. Considering both THP-1 and SH-SY5Y are cancer cells and that they have a 541 
dominant glycolytic metabolism [60, 61], our analyses shows that independent of this, oxysterol 542 
metabolism is significantly distinct in the mitochondrial fractions of these cells. 543 
 544 
After the autoxidised oxysterol 7ketoOHC, 27OHC was the abundant enzymatically produced 545 
oxysterol in SH-SY5Y mitochondrial fractions confirming the mitochondrial activity of sterol 27-546 
hydroxylase, and this is consistent with previous findings [2,56,57]. The levels of cholesterol were 547 
lower in the endoplasmic reticulum and mitochondrial fractions than the whole cells of both THP-548 
1 monocytes and SH-SY5Y cells. Plasma membrane contains majority of cholesterol at cellular 549 
levels and this explains the minimal amount of cholesterol measured in THP-1 and SH-SY5Y 550 
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subfractions and that majority of cholesterol is retained in the membrane fractions of these cells 551 
[61, 62]. Despite the minimal cholesterol levels in the mitochondrial fractions, the oxysterol levels 552 
were comparable to that of the whole cells, particularly in the THP-1 monocytes. This highlights 553 
mitochondria as one of the primary cellular compartment housing significant oxysterol 554 
metabolism at the cellular level. 555 
 556 
In summary, we have developed a robust, a highly sensitive and selective method for extraction 557 
and quantification of oxysterols from mitochondria. We show the application of our method to 558 
identify mitochondrial specific oxysterol metabolism in different cell lines including SH-SY5Y, 559 
PBMC and THP-1. The method offers versatility in its application to tissue sections, cell lines and 560 
blood leukocytes for profiling the oxysterol distribution and in particular, to study 561 
cholesterol/oxysterol metabolism in the context of disease. 562 
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 Fig. 1: Methodology- work flow for isolation of lipids and oxysterols from cellular and 771 
subcellular compartments. Three cell types - THP-1 monocytes, peripheral blood mononuclear 772 
cells (PBMC) and SH-SY5Y neuroblastoma cells- were used for this analysis. The work flow 773 
involves stage A - isolation of mitochondria from whole cells, stage B - sample lysis and lipid 774 
extraction- cholesterol and protein measurements, stage C - oxysterol isolation using solid phase 775 
extraction (SPE) followed by LC-MS/MS profiling using a multistep gradient of solvent A - 70% 776 
methanol (MeOH) + 30% H2O + 0.1% formic acid and solvent B - 90% isopropanol (IPA) + 10% 777 
MeOH and 0.1% formic acid. 778 
 Fig. 2: Comparison of oxysterol recovery and matrix effects from three methods. (A) Three 779 
methods; M1 (methanol (MeOH) cell lysis and SPE oxysterol extraction, M2 dimethylsulfoxide 780 
(DMSO) cell lysis, methanol:dichloromethane (MeOH:DCM) lipid isolation and SPE oxysterol 781 
extraction, M3 (0.1% Triton X-100 + DMSO cell lysis, MeOH:DCM lipid extraction and SPE 782 
oxysterol extraction) were compared. Authentic standards were prepared in 40% methanol 0.1% 783 
formic acid (without cellular matrix and no SPE extraction) and used as the control (black bars). 784 
M3 improved chromatographic resolution of 10ng authentic oxysterol standards mixed with whole 785 
cell lysate as the matrix and isolated using the methodology described in Fig. 1. (B), (C) and (D) 786 
compares the recovery (ratio of +SPE peak area/No SPE peak area) expressed as % for the 787 
authentic standards in matrix using extraction methods M1 [29], M2 [38] and M3- developed in 788 
this work. M3 showed >70% recovery for all nine oxysterols. Measurements were done using 789 
standards at 1ng.µl-1 and are mean ± S.D. of 3-4 independent replicates. 790 
Fig. 3: Method validation for oxysterol quantification in THP1 subcellular fractions. (A) 791 
Standard curve and R2 goodness-of-fit of the curve for oxysterol standards produced using 792 
method M3. (B) Co-efficient of variation of standard curve and identification of lower limit of 793 
quantification (LLOQ) and upper limit of quantification (ULOQ). LC injections for the standards 794 
were 10µl and the values are mean ± S.D. of 3-4 independent extractions and LC-MS/MS 795 
analysis. (C) Chromatographic resolution of oxysterols extracted from THP-1 monocytes using 796 
the methods M1, M2 and M3. (D) Chromatography of mono and dihydroxycholesterols from 797 
monocytes ranging from 105 to 107. (E) Quantification of oxysterols, cholesterol and protein in 798 
THP-1 monocytes and their linearity with number of cells used for extraction and LC-MS/MS 799 
analysis. # indicates the amount detected was close to the LLOQ and are unreliable 800 
measurements. (F) Reproducibility analysis of oxysterol extraction and quantitation. Data shown 801 
are mean ± S.D. of biological replicates (n=3-5). Student’s t-test (cut off *, p ≤ 0.05) was used to 802 
check statistically significant differences in the measurements (absolute and log transformed); ns 803 
denotes not significant. 804 
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Fig. 4: Oxysterol profiles in tissues. (A) Oxysterol profiles in brain tissues of mice fed with 805 
normal chow diet vs. high fat diet. Statistical significance was calculated using paired t-test (two-806 
tailed) with α=0.05; *, P < 0.05. (B) Cholesterol levels in brain tissues of mice fed with normal 807 
chow diet vs. high fat diet.  Values are mean ± S.D (n=5). (C) Cholesterol and protein levels in 808 
the mitochondria and whole peripheral blood mononuclear (PBMC). (D) Changes in oxysterol 809 
levels of mitochondria isolated from blood stored under various conditions. Values are mean ± 810 
S.D. (n=2 to 5). ANOVA analysis and statistical test using Holm-Sidak method, with α = 0.05 811 
without assuming a consistent S.D were performed to check for statistically significant differences 812 
in mitochondrial oxysterols isolated from blood stored under the four storage periods- 1 813 
hour/room temperature, 24 hour/ 4°C, 48 hour/ 4°C a nd 72 hour/ 4°C.  814 
Fig. 5: Oxysterol profiles in different cell types. (A) Principal component analysis (PCA) of 815 
mitochondrial and whole cell oxysterol measurements of SH-SY5Y neuroblastoma cells vs. blood 816 
PBMCs. (B) PCA of mitochondrial and whole cell oxysterol measurements of SH-SY5Y vs. THP-817 
1 monocytes. (C) Mitochondrial oxysterol levels and (D) Whole cell oxysterol levels in SH-SY5Y 818 
and THP-1. E, Compartment specific oxysterol profiles in SH-SY5Y. Values are mean ± S.D. 819 
(n=3). Values are mean ± S.D. (n=3).Statistical significance calculated by unpaired t-test Welch's 820 
correction (two-tailed) on log data, ns, not significant, * p< 0.05, **P<0.005, *** P<0.0005.  821 
Fig. 6: Cholesterol-oxysterol metabolic pathway. Cholesterol is converted to bile acids by 822 
classical and acidic pathway. Enzymes specific to mitochondria and endoplasmic reticulum are 823 
colour coded. 824 
 825 
Supplementary Figures-Titles and legends 826 
 Fig. S1: Purification analysis of mitochondria and whole cell fractions. (A) Western and  (B) 827 
immunoblot analysis of mitochondria (Mito) and whole cell (WC) fraction of SH-SY5Y 828 
neuroblastoma cells, (C) Western blot and (D) immunoblot analysis of mitochondria (Mito) and 829 
whole blood cell (WBC) fraction of PBMCs,using calnexin (ER) and ATP5A (mitochondrial) 830 
markers to assess the purity of subfractions (see materials and methods for details).  831 
 Fig. S2: Chromatography of authentic oxysterol standards extracted from a cell matrix. (A) 832 
Differences in the two peak areas of dihydroxycholesterols without solid phase extraction (SPE) 833 
authentic standards and extracted from whole cell matrix with SPE. Statistically significant 834 
differences were determined by student’s t-test and are denoted by **, p<0.005; ***, p<0.0-0005 835 
and ns, not significant (B) LC-MS/MS analysis of oxysterols extracted from whole cell lysate 836 
matrix using method M3 developed in this work. 837 
26 
 
 Fig. S3: Linearity assessment of oxysterol quantification in THP-1. THP-1 cell numbers of 838 
105, 106 and 107 were used as the starting material for extraction of oxysterols, followed by LC-839 
MS/MS quantification of oxysterol concentration. Cholesterol analysis was by Amplex Red assay 840 
and protein by BCA assay. Regression analysis was done across the data to assess the 841 
goodness-of best fit and R2, plotted for each of the components analysed. Data shown are mean 842 
± S.D of biological replicates (n=3-5).  843 
 Fig. S4: Cholesterol measurement in THP-1 subcellular fractions stored for different time 844 
periods. 107 THP-1 monocytes were used for subcellular fractionation and the fractions were 845 
stored for 1 day and 7 days followed by oxysterol extraction and LC-MS/MS quantification. Data 846 
shown are mean ± S.D of biological replicates (n=3-5). Student’s t-test (cut off *, p ≤ 0.05) was 847 
used to check statistically significant differences in the measurements; ns denotes not significant. 848 
Fig. S5: Oxysterol profiles in tissues. (A) Oxysterols in brain sections of mice fed with normal 849 
diet and high fat diet. Values are mean ± S.D. (n=5). Statistically significant differences in the 850 
oxysterol levels within the two groups were tested by ANOVA and unpaired t-test (two-tailed) 851 
indicated by *, P<0.05; **, P< 0.005;***,P<0.0005. (B) Oxysterols in peripheral blood 852 
mononuclear cells extracted from whole blood stored under various conditions. Values are mean 853 
± S.D (n=4). Statistical test using unpaired t-test with α = 0.05 were performed to check for 854 
statistically significant differences in oxysterols from PBMCs isolated from blood stored under the 855 
four storage periods- 1 hour/room temperature, 24 hour/ 4°C, 48 hour/ 4°C and 72 hour/ 4°C. (C) 856 
Oxysterol distribution in blood mitochondria and PBMC (1 h RT stored samples). Values are 857 
mean ± S.D (n=3 to 4).  858 
 Fig.S6: Oxysterol and cholesterol distributions in different cell lines. (A) PCA plots of THP-859 
1 monocytes vs. PBMCs. (B) Cholesterol levels in cellular compartments of SH-SY5Y cells. (C) 860 
Cholesterol levels in cellular compartments of THP-1 monocytes (D) Compartmental oxysterol 861 
levels in THP-1 monocytes. Measurements are shown for mitochondria (M), endoplasmic 862 
reticulum/mitochondrial (ER/M) and whole cell (WC) fractions. Values are mean ± S.D (n=6). 863 
Statistical significance was calculated using unpaired t-test; * P<0.05. 864 
Main Table 





CV CE Retention 
time (min) 
7α hydroxycholesterol 367.35 -> 147.42 367.35 -> 159.12 94 22, 22 18, 20.70 
22(S)-hydroxycholesterol-d7 392.19 -> 159.11 392.19 -> 105.4 2 24, 44 15.15 
7α,24(S)dihydroxycholesterol 383.11 -> 81.05 383.11 -> 105.03 38 30, 42 6.08, 10.20 
7α,25dihydroxycholesterol 383.31 -> 81.05 383.31 -> 95.09 12 30, 30 6.04, 10.62 
7α,27dihydroxycholesterol 401.43 -> 159.05 401.43 -> 81.06 40 24, 34 6.83, 11.97 
24(S)hydroxycholesterol 367.35 -> 95.03 367.35 -> 147.09 12 30, 24 15.98 
25hydroxycholesterol 367.35 -> 147.09 367.35 -> 158.54 40 24,18 16.34 
27hydroxycholesterol 385.35 -> 81.06 385.35 -> 95.09 48 30,26 17.05 









• New method for extraction and quantification of mono and dihydroxysterols from 
mitochondria  
• Method offers high sensitivity and selectivity allowing quantification of oxysterols at 
>5pg.µl-1 
• Successful application to tissue, primary cells and cell lines  
• Common oxysterol metabolites are present in blood and brain cell mitochondria 
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